These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 47516)

  • 1. Letter: diogenes syndrome.
    Flannery GR; Rolland JM; Nairn RC
    Lancet; 1975 Mar; 1(7909):750-1. PubMed ID: 47516
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Levamisole.
    Lancet; 1975 Mar; 1(7906):574-5. PubMed ID: 47045
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Levamisole.
    Lancet; 1975 Feb; 1(7903):389. PubMed ID: 46527
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various aspects of the mechanism of action of levamisole].
    Chumakova MM
    Ter Arkh; 1978; 50(9):146-53. PubMed ID: 360467
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Levamisole.
    Symoens J
    Lancet; 1975 Apr; 1(7911):867. PubMed ID: 48105
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Levamisole.
    Lancet; 1975 Jan; 1(7899):151-2. PubMed ID: 46060
    [No Abstract]   [Full Text] [Related]  

  • 7. Levamisole as an immunotherapeutic agent in the treatment of cancer.
    Amery WK
    World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Levamisole in the treatment of cancer.
    Ward HW
    Lancet; 1976 Mar; 1(7959):594-5. PubMed ID: 55877
    [No Abstract]   [Full Text] [Related]  

  • 9. Levamisole: a synthetic immunopotentiator under evaluation.
    Hadden JW
    Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Levamisole.
    Webster DJ; Hughes LE
    Lancet; 1975 Apr; 1(7912):917-8. PubMed ID: 47559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Levamisole--immunotherapy for everyone?].
    Brincker H
    Ugeskr Laeger; 1977 Feb; 139(9):517-20. PubMed ID: 320738
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro stimulation of tumor-associated immunity in prostatic cancer by levamisole.
    Zamora S; Bhatti RA; Ablin RJ; Rao R; Baumgartner G; Guinan PD
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(1):57-9. PubMed ID: 574794
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of levamisole treatment in cancer patients.
    Amery WK; Verhaegen H
    J Rheumatol Suppl; 1978; 4():123-35. PubMed ID: 366137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of L-tryptophan.
    Gold J
    Oncology; 1970; 24(4):291-303. PubMed ID: 5446186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: action of levamisole on the restoration of cellular immunity in man].
    Pasquier P; Vidal M; Couture J; Niel G; Floc'h F; Werner GH
    Nouv Presse Med; 1975 Nov; 4(38):2736. PubMed ID: 1105423
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experiences with levamisole.
    Gross RL
    Adv Exp Med Biol; 1976; 73 PT-A():424-7. PubMed ID: 793353
    [No Abstract]   [Full Text] [Related]  

  • 17. Levamisole as an immunostimulant.
    Pár A
    Ther Hung; 1980; 28(4):163-7. PubMed ID: 6782693
    [No Abstract]   [Full Text] [Related]  

  • 18. Levamisole immunotherapy of experimental transitional cell carcinoma.
    Lamm DL; Yee GN; Reichert DF; Radwin HM
    Invest Urol; 1979 Jan; 16(4):286-8. PubMed ID: 429122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of protamine derivatives and nitrogen mustard on the growth of the Walker 256 rat carcinoma.
    Garvie WH
    Br J Cancer; 1965 Sep; 19(3):519-26. PubMed ID: 5833070
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral activity of mitomycin C (NSC-26980) on Walker 256 (intramuscular) tumor.
    Bradner WT
    Cancer Chemother Rep; 1968 Apr; 52(3):389-91. PubMed ID: 5670720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.